Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06249880 · ClinicalTrials.gov registry record
Pediatric Normative Markerless Movement Analysis
A clinical trial of Pediatric ALL and Adolescent, sponsored by MultiCare Health System Research Institute.
- Recruiting
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT06249880: Recruiting study of Pediatric ALL and Adolescent, sponsored by MultiCare Health System Research Institute.
NCT06249880 is a study of Pediatric ALL and Adolescent that is actively recruiting participants, run by MultiCare Health System Research Institute. The registered enrollment target is 40 participants, below the 1,646-participant average among 21 other Pediatric ALL trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06249880, a study of Pediatric ALL and Adolescent, is actively recruiting participants, sponsored by MultiCare Health System Research Institute.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this project is to collect baseline data from a normative population of 20 children that gender and age matches the population of patients expected to be treated by Mary Bridge Children's Research \& Movement Lab.
Primary Outcome
The purpose of this normative data collection study is to collect baseline data from a normative population of children/adolescents using force plates and 3D markerless motion capture. Together these are used to calculate a normative range of body position and joint angles (kinematics), as well as joint loads and ground reaction forces (kinetics) during prescribed activities.
Conditions Studied
Interventions
- OTHER Observation
Study Locations (1)
Washington
- Mary Bridge Children's Therapy Unit - Research & Movement Lab - Puyallup
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-03-01 |
| Est. Completion | 2028-12 |
What NCT06249880 shows while recruiting
NCT06249880 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,646-participant average among 21 other Pediatric ALL trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Pediatric ALL appearing as the primary indexed condition, and to 1 intervention - of which Observation is the first listed.
NCT06249880 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT06249880 about?
NCT06249880 is a clinical study titled "Pediatric Normative Markerless Movement Analysis". The objective of this project is to collect baseline data from a normative population of 20 children that gender and age matches the population of patients expected to be treated by Mary Bridge Children's Research \& Movement Lab.
What is the current status of trial NCT06249880?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2024-03-01. Estimated completion is 2028-12.
What conditions does trial NCT06249880 study?
This clinical trial studies the following conditions: Pediatric ALL, Adolescent.
What interventions are being tested in trial NCT06249880?
The interventions under investigation include: Observation (OTHER).
Who is sponsoring clinical trial NCT06249880?
This trial is sponsored by MultiCare Health System Research Institute, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06249880 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pediatric ALL
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06249880's enrollment target sits among peer trials
40 14th of 21 higher than 7 of 21 other Pediatric ALL trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pediatric ALL trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)
RECRUITING · NA
-
PRotein Optimization With eXercise to Improve MUscle Mass and Functional outcomeS
RECRUITING · NA
-
Study of CD19-directed Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia
RECRUITING · Phase 1
-
Using Augmented Reality to Promote Physical Activity in Children With Cerebral Palsy
RECRUITING · NA
-
Feasibility/Acceptability of Attentional-Control Training in Survivors
RECRUITING · NA
-
Pharmacokinetics of Drugs Administered to Children
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI